Selection of an in vitro carcinogenicity test for derivatives of the carcinogen hexamethylphosphoramide.
The demonstration that hexamethylphosphoramide (HMPA) possesses potent carcinogenic properties has raised doubts about the safety of exposure to other phosphoric amides. In order to define a suitable short-term test with which to evaluate such analogues, the response of the Salmonella typhimurium mutation assay of Ames and cell transformation assay of Styles to HMPA and 3 selected analogues has been studied. These analogues were the related leukaemogen phosphoramide, the putative non-carcinogen, phosphoric trianilide and N.N'N''-trimethylphosphorothioic triamide, a compound of unknown and hitherto unpredictable properties. While both tests found the trianilide negative, the Ames test failed to detect phosphoramide as positive and gave an erratic and predominantly negative response to HMPA. In contrast, the transformation assay found both phosphoramide and HMPA positive. This test response profile indicates that the transformation assay is the preferred test with which to evaluate analogues of HMPA for potential carcinogenicity. Some structural requirements for potential carcinogenicity within this class of compounds are tentatively deduced.
D000813:Anilides / Q000633:toxicity; D002273:Carcinogens; D002470:Cell Survival / Q000187:drug effects; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced*; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D006492:Hempa / Q000633:toxicity*; D066298:In Vitro Techniques; D009154:Mutation / Q000187:drug effects; D009943:Organophosphorus Compounds / Q000633:toxicity*; D009946:Organothiophosphorus Compounds / Q000633:toxicity; D012486:Salmonella typhimurium / Q000187:drug effects*
D000813:Anilides; D002273:Carcinogens; D009943:Organophosphorus Compounds; D009946:Organothiophosphorus Compounds; D006492:Hempa